Protein 1700020A23Rik Activators encompass a selection of chemical compounds that, through various signaling pathways, enhance the functional activity of Protein 1700020A23Rik. Forskolin, by increasing cAMP, activates PKA that could phosphorylateProtein 1700020A23Rik Activators refer to a specific group of chemical compounds that enhance the functional activity of Protein 1700020A23Rik through distinct signaling mechanisms. Forskolin, with its ability to raise intracellular cAMP levels, indirectly promotes the activity of Protein 1700020A23Rik by activating PKA, which might phosphorylate Protein 1700020A23Rik or related proteins to enhance its functional role. Phorbol 12-myristate 13-acetate (PMA) activates PKC, potentially leading to the phosphorylation and consequential activation of Protein 1700020A23Rik. Ionomycin facilitates an increase in intracellular calcium that could trigger Protein 1700020A23Rik activity if it is regulated by calcium-mediated signaling.
Furthermore, Retinoic Acid has the potential to modulate the gene expression of Protein 1700020A23Rik, thereby enhancing its activity through transcriptional regulation. Insulin, through the PI3K/Akt pathway, can phosphorylate and activate Protein 1700020A23Rik if it is a part of this cascade. The use of the cAMP analog 8-Bromo-cAMP provides a resistant pathway to activate PKA, which in turn could enhance the activity of Protein 1700020A23Rik if it is under PKA regulation. Ouabain, by inhibiting the Na+/K+ ATPase, might alter intracellular ion balances, indirectly leading to the activation of Protein 1700020A23Rik through secondary messenger systems. Lastly, Bisindolylmaleimide I, though typically a PKC inhibitor, could indirectly activate Protein 1700020A23Rik by shifting the equilibrium in cellular signaling pathways, potentially enhancing its activity through an alternative PKC isoform or related signaling pathway. These activators, through targeted cellular and molecular interactions, serve to enhance the activity of Protein 1700020A23Rik by affecting the pathways and processes to which it is integrally connected.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC). Activation of PKC could lead to downstream activation of Protein 1700020A23Rik by phosphorylation or by modulating the cellular environment to favor its active state. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore, which increases intracellular calcium levels, potentially activating Protein 1700020A23Rik if it is regulated by calcium-dependent signaling pathways. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit certain types of kinases. Inhibition of a kinase that normally suppresses Protein 1700020A23Rik could result in the enhanced activity of the protein. | ||||||
NOC-18 | 146724-94-9 | sc-202247 sc-202247A sc-202247B sc-202247C | 10 mg 50 mg 100 mg 500 mg | $51.00 $184.00 $305.00 $1122.00 | 18 | |
Nitric oxide donors release nitric oxide, which can activate guanylyl cyclase, increasing cGMP levels in cells, thereby potentially enhancing the activity of Protein 1700020A23Rik if it is cGMP-dependent. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium is known to inhibit glycogen synthase kinase-3 (GSK-3). If Protein 1700020A23Rik is negatively regulated by GSK-3, inhibition by lithium could enhance its activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can modulate gene expression through retinoic acid receptors. If Protein 1700020A23Rik is regulated by such mechanisms, retinoic acid may enhance its expression and activity. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the PI3K/Akt signaling pathway, which can result in the phosphorylation and activation of various proteins. If Protein 1700020A23Rik is a downstream target in this pathway, insulin could enhance its activity. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
This cAMP analog is resistant to degradation by phosphodiesterases and can activate PKA. If Protein 1700020A23Rik is PKA-dependent, 8-Bromo-cAMP could be used to enhance its activity. | ||||||
Ouabain-d3 (Major) | sc-478417 | 1 mg | $516.00 | |||
Ouabain inhibits the Na+/K+ ATPase pump, leading to alterations in intracellular ion concentrations. This could activate signaling pathways or secondary messengers that enhance the activity of Protein 1700020A23Rik. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
This compound is a selective PKC inhibitor; paradoxically, inhibiting one PKC isoform could lead to compensatory activation of another pathway or PKC isoform that might enhance the activity of Protein 1700020A23Rik. | ||||||